S. Menshikova

Systemic control of cerebral metastases in a patient with HER2-positive metastatic breast cancer. Clinical case

M. Stenina, M. Frolova, S. Menshikova, 2019, Medical Council.

Ribociclib in the first-line therapy for metastatic hormone-dependent HER2-negative breast cancer in patients with intact ovarian function

M. Frolova, S. Menshikova, E. Glazkova, 2018, Medical Council.

Multiple Myeloma in Russia (First Results of the Registration Trial)

N. Stepanova, E. Filatova, L. Mendeleeva, 2017 .